About Us

Phusjon Group started life as Censere Group in 2002 and was re-named Phusjon Group in 2018. As Censere Group's businesses and services expanded we came to the realisation that we could more effectively connect with clients by adopting focused brands for each logical group of services, thus the evolution of Censere Group into Phusjon Group and the current structure comprising 3 focused brands: Censere, Stratiqa and Ausus Advisory.


Censere was the founding business of Phusjon Group and provides comprehensive valuation and financial modeling services. Censere was established in 2002 and currently operates through a dedicated network of 16 offices across the United States, Asia and Europe. Valuation services extend to:

  • Businesses
  • Derivatives
  • Illiquid Debt
  • Intangible Assets
  • Real Estate
  • Machinery & Equipment
  • Inventory

Please visit Censere's website for more information: www.censere.com


Stratiqa was established in 2012 and is a boutique strategic advisory firm. Stratiqa was acquired by Phusjon Group in 2016. It undertakes contentious valuations and buy-side/sell-side advisory work on behalf of clients. Stratiqa currently maintains offices in Hong Kong, New York, San Francisco and Singapore. Primary services include:

  • Fairness Opinions
  • Expert Witness Opinions
  • ESOP Modeling and Advisory
  • Strategic Advisory
  • M&A Advisory

Please visit Stratiqa's website for more information: www.stratiqa.com


Ausus Advisory traces its roots back to 2014 when Censere first launched its forensic accounting and investigations practice. In 2017 this was re-organised into Ausus Advisory to better showcase its services and distinguish it from Censere. Ausus Advisory co-locates with Censere and thus benefits from Censere's dedicated network of 16 offices. Ausus Advisory provides a range of risk advisory services including:

  • Forensic Accounting
  • Fraud & Corruption Investigations
  • Background Investigations
  • Due Diligence - Financial, Commercial, Background
  • IT Forensics

Please visit Ausus Advisory's website for more information: www.ausus.com